Immunophenotypic, cytogenetic and clinical features of 113 acute lymphoblastic leukaemia patients in China

Annals of the Academy of Medicine Singapore

Volumn 39, Issue 1, 2010, Pages 49-53

  Tong, Haixia ^a   Zhang, Jihong ^a   Lu, Chunwei ^a   Liu, Zhuogang ^a   Zheng, Yingchun ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Diagnosis and typing; Flow cytometry; Karyotype analysis

Indexed keywords

CD14 ANTIGEN; CD15 ANTIGEN; CD19 ANTIGEN; CD2 ANTIGEN; CD20 ANTIGEN; CD22 ANTIGEN; CD3 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CD5 ANTIGEN; CD7 ANTIGEN; CD79A ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; HEMOGLOBIN; HLA DR ANTIGEN; IMMUNOGLOBULIN M; MICROSOMAL AMINOPEPTIDASE; STEM CELL FACTOR RECEPTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ANTIGEN EXPRESSION; ARTICLE; B CELL LEUKEMIA; BLAST CELL; BONE MARROW; CANCER PATIENT; CD34 SELECTION; CHILD; CHINA; CHINESE; CHROMOSOME ANALYSIS; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; KARYOTYPING; LEUKEMIA CELL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; T CELL LEUKEMIA; THROMBOCYTE COUNT;

EID: 75749121474     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Foa R, Vitale A. Towards an integrated classifi cation of adult acute Lymphoblastic leukemia. Rev Clin Exp Hematol 2002;6:181-99.
2. Bene MC. Immunophenotyping of acute leukaemias. Immunol Lett 2005;98:9-21.
3. Chan NP, Ma ES, Wan TS, Chan LC. The spectrum of acute lymphoblastic leukemia with mature B-cell phenotype. Leuk Res 2003;27:231-4.
4. Plasschaert SL, Kamps WA, Vellenga E, de Vries EGE, de Bont ES. Prognosis in childhood and adult acute lymphoblastic leukaemia: a question of maturation? Cancer Treat Rev 2004;30:37-51.
5. Campana D, Behm FG. Immunophenotyping of leukemia. J Immunol Methods 2000;243:59-75.
6. Paredes-Aguilera R, Romero-Guzman L, Lopez-Santiago N, Burbano-Ceron L, Camacho-Del Monte O, Nieto-Martinez S. Flow cytometric analysis of cell-surface and intracellular antigens in the diagnosis of acute leukemia. Am J Hematol 2001;68:69-74.
7. Asgarian Omran H, Shabani M, Shahrestani T, Sarafnejad A, Khoshnoodi J, Vossough P, et al. Immunophenotypic subtyping of leukemic cells from Iranian patients with acute lymphoblastic leukaemia: association to disease outcome. Iran J Immunol 2007;4:15-25.
8. Vitale A, Guarini A, Ariola C, Mancini M, Mecucci C, Cuneo A, et al. Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496. protocol. Blood 2006;107:473-9.
9. Vitale A, Guarini A, Ariola C, Meloni G, Perbellini O, Pizzuti M, et al. Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial. Haematologica 2007;92:342-8.
10. Attarbaschi A, Mann G, Konig M, Steiner M, Strehl S, Schreiberhuber A, et al. Mixed lineage leukemia-rearranged childhood pro-B and CD10-negative pre-B acute lymphoblastic leukemia constitute a distinct clinical entity. Clin Cancer Res 2006;12:2988-94.
11. Uckun FM, Sather HN, Gaynon PS, Arthur DC, Trigg ME, Tubergen DG, et al. Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 1997;90:28-35.
12. Larson RA, Dodge RK, Burns CP, Lee EJ, Stone RM, Schulman P, et al. A fi ve drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 8811. Blood 1995;85:2025-37.
13. Czuczman MS, Dodge RK, Stewart CC, Frankel SR, Powell BL, Szatrowski TP, et al. Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: Cancer and Leukemia Group B. Blood 1999;93:3931-9.